We assign a technical rating of 0 out of 10 to ESLA. ESLA's overall performance in the market is below average. Also recent evolutions are not that positive. Both the medium and short term picture give negative signs.
- Both the long and short term trends are negative. It is better to avoid buying stocks with negative trends.
- When comparing the yearly performance of all stocks, ESLA is a bad performer in the overall market: 90% of all stocks are doing better.
- ESLA is one of the lesser performing stocks in the Biotechnology industry. 68% of 525 stocks in the same industry do better.
- ESLA is currently trading in the lower part of its 52 week range, which is not a good signal. Certainly not because the S&P500 Index is trading near new highs.
- In the last month ESLA has a been trading in the 0.93 - 1.80 range, which is quite wide. It is currently trading near the lows of this range.
- Prices have been falling strongly lately, it is better to avoid new long positions here.
- Considerably lower volume is observed in the last couple of days.
ESLA has a poor technical rating and the quality of the setup is also not perfect at the moment. Price movement has been a little bit too volatile to find a nice entry and exit point. It is probably a good idea to wait for a consolidation first.
More info and screens
0.87
When analyzing the support we can see 2 important areas.
- A support zone ranging from 0.94 to 0.95. This zone is formed by a combination of multiple trend lines in the daily time frame.
- A support zone ranging from 0.88 to 0.88. This zone is formed by a combination of multiple trend lines in multiple time frames.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | DOWN | NEGATIVE | The long term trend for ESLA is down. |
| ChartMill Short Term Trend Indicator | DOWN | NEGATIVE | The short term trend for ESLA is down. |
| ChartMill Relative Strength | 10.48 | NEGATIVE | ESLA has a low relative strength, it was outperformed by 89.52% off all stocks on the market. |
| Simple Moving Average/SMA (20) | DOWN | NEGATIVE | The current price of ESLA is below a declining SMA(20). |
| Simple Moving Average/SMA (50) | DOWN | NEGATIVE | The current price of ESLA is below a declining SMA(50). |
| Simple Moving Average/SMA (200) | UP | MIXED | The current price of ESLA is below the rising SMA(200). |
| Relative Strength Index/RSI (14) | 33.35 | NEUTRAL | The RSI value for ESLA is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | -0.03 | NEGATIVE | The MACD value suggests ESLA has a negative trend, although the MACD value is rising. |
| Stochastics (14,3) | 10.84 | OVERSOLD | The low Stochastics value suggests ESLA may be oversold. |
| Average True Range in percent/ATR (20) | 17.91 | HIGH VOLATILITY | The high ATR as a percentage value for ESLA suggests high volalility. |
| Average Directional Index/ADX (14) | 27.71 | POSITIVE | The high ADX value value for ESLA suggests a strong trend. |
0.994
+0.02 (+2.47%)
ESTRELLA IMMUNOPHARMA INC / ESLA FAQ
What is the ChartMill technical rating of ESTRELLA IMMUNOPHARMA INC (ESLA) stock?
ChartMill assigns a technical rating of 0 / 10 to ESLA.
Can you provide the trend direction for ESTRELLA IMMUNOPHARMA INC?
The current trend direction for ESTRELLA IMMUNOPHARMA INC (ESLA) is Bearish.
What is the RSI signal for ESTRELLA IMMUNOPHARMA INC (ESLA) stock?
ESTRELLA IMMUNOPHARMA INC (ESLA) has an RSI value of 33.3548. This indicates that the stock is currently neutral.
What is the MACD signal for ESTRELLA IMMUNOPHARMA INC (ESLA) stock?
The MACD indicator for ESTRELLA IMMUNOPHARMA INC (ESLA) has a value of -0.0344536, indicating a bearish trend.
What is the short term momentum for ESTRELLA IMMUNOPHARMA INC (ESLA) stock?
The short term momentum for ESTRELLA IMMUNOPHARMA INC (ESLA) is negative.